Synthesis and properties of cyclopropane-derived peptidomimetics

Accounts of Chemical Research

Volumn 39, Issue 7, 2006, Pages 433-442

  Reichelt, Andreas ^a   Martin, Stephen F ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPROPANE DERIVATIVE; MATRIX METALLOPROTEINASE; PEPTIDE; PROTEINASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; MOLECULAR MIMICRY; SYNTHESIS;

CYCLOPROPANES; MATRIX METALLOPROTEINASES; MODELS, MOLECULAR; MOLECULAR MIMICRY; PEPTIDES; PROTEASE INHIBITORS;

EID: 33746898558     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar030255s     Document Type: Article

References (36)

1. Babine, R. E.; Bender, S. L. Molecular Recognition of Protein-Ligand Complexes: Applications to Drug Design. Chem. Rev. 1997, 97, 1359-1472.
2. Mann, A. Conformational Restriction and/or Steric Hindrance in Medicinal Chemistry. In The Practice of Medicinal Chemistry, 2nd ed.; Wermuth, C. G., Ed.; Academic Press: London, U.K., 2003; pp 233-250.
3. Nakanishi, H.; Kahn, M. Design of Peptidomimetics. In The Practice of Medicinal Chemistry, 2nd ed.; Wermuth, C. G., Ed.; Academic Press: London, U.K., 2003; pp 477-500 and references therein.
4. Böhm, H.-J.; Klebe, G. What Can We Learn from Molecular Recognition in Protein-Ligand Complexes for the Design of New Drugs? Angew. Chem., Int. Ed. Engl. 1996, 35, 2588-2614.
5. Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular Properties that Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002, 45, 2615-26623.
6. Tyndall, J. D. A.; Pfeiffer, B.; Abbenante, G.; Fairlie, D. P. Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure. Chem. Rev. 2005, 105, 793-826.
7. Tyndall, J. D. A.; Nall, T.; Fairlie, D. P. Proteases Universally Recognize Beta Strands in Their Active Sites. Chem. Rev. 2005, 105, 973-999.
8. Hruby, V. J.; Li, G.; Haskell-Luevano, C.; Shenderovich, M. Design of Peptides, Proteins, and Peptidomimetics in Chi Space. Biopolymers 1997, 43, 219-266.
9. Martin, S. F.; Austin, R. E.; Oalmann, C. J. Stereoselective Synthesis of 1,2,3-Trisubstituted Cyclopropanes as Novel Dipeptide Isosteres. Tetrahedron Lett. 1990, 31, 4731-4734.
10. Williams, D. H.; Stephens, E.; O'Brien, D. P.; Zhou, M. Understanding Noncovalent Interactions: Ligand Binding Energy and Catalytic Efficiency from Ligand-Induced Reductions within Receptors and Enzymes. Angew. Chem., Int. Ed. 2004, 43, 6596-6616.
11. Doyle, M. P.; Pieters, R. J.; Martin, S. F.; Austin, R. E.; Oalmann, C. J.; Müller, P. High Enantioselectivity in the Intramolecular Cyclopropanation of Allyl Diazoacetates Using a Novel Rhodium(II) Catalyst. J. Am. Chem. Soc. 1991, 113, 1423-1424.
12. Doyle, M. P.; Austin, R. E.; Bailey, A. S.; Dwyer, M. P.; Dyatkin, A. B.; Kalinin, A. V.; Kwan, M. M. Y.; Liras, S.; Oalmann, C. J.; Pieters, R. J.; Protopopova, M. N.; Raab, C. E.; Roos, G. H. P.; Zhou, Q.-L.; Martin, S. F. Enantioselective Intramolecular Cyclopropanations of Allylic and Homoallylic Diazoacetates and Diazoacetamides Using Chiral Dirhodium(II) Carboxamide Catalysts. J. Am. Chem. Soc. 1995, 117, 5763-5775.
13. Martin, S. F.; Dwyer, M. P. Iodocyclopropanes as Versatile Intermediates for the Synthesis of Substituted Cyclopropanes. Tetrahedron Lett. 1998, 39, 1521-1524.
14. Martin, S. F.; Austin, R. E.; Oalmann, C. J.; Baker, W. R.; Condon, S. L.; deLara, E.; Rosenberg, S. H.; Spina, K. P.; Stein, H. H.; Cohen, J.; Kleinert, H. D. 1,2,3-Trisubstituted Cyclopropanes as Conformationally Restricted Peptide Isosteres: Application to the Design and Synthesis of Novel Renin Inhibitors. J. Med. Chem. 1992, 35, 1710-1721.
15. Dickens, J. P.; Donald, D. K.; Kneen, G.; McKay, W. R. (Searle, G. D., and Co.). U.S. Patent 4,599,361, 1986, p 10; U.S. Patent 4,743,587, 1988, p 13.
16. Martin, S. F.; Oalmann, C. J.; Liras, S. Cyclopropanes as Conformationally Restricted Peptide Isosteres. Design and Synthesis of Novel Collagenase Inhibitors. Tetrahedron 1993, 49, 3521-3532.
17. Reichelt, A.; Gaul, C.; Frey, R. R.; Kennedy, A.; Martin, S. F. Design, Synthesis, and Evaluation of Matrix Metalloprotease Inhibitors Bearing Cyclopropane-Derived Peptidomimetics as P1′ and P2′ Replacements. J. Org. Chem. 2002, 67, 4062-4075.
18. 3-Mediated Amidation Reactions to Solution Phase Peptide Synthesis. Tetrahedron Lett. 1998, 39, 1517-1520.
19. Spurlino, J. C.; Smallwood, A. M.; Carlton, D. D.; Banks, T. M.; Vavra, K. J.; Johnson, J. S.; Cook, E. R.; Falvo, J.; Wahl, R. C.; Pulvino, T. A.; Wendoloski, J. J.; Smith, D. L. 1.56 Å Structure of Mature Truncated Human Fibroblast Collagenase. Proteins: Struct., Funct., Genet. 1994, 19, 98-109.
20. Schiller, P. W. Conformational Analysis of Enkephalin and Conformation-Activity Relationships. In Opioid Peptides: Biology, Chemistry, and Genetics; Udenfried, S., Meienhofer, J., Eds.; The Peptides: Analysis, Synthesis, Biology, Vol. 6.; Academic Press: New York, 1984; pp 219-268.
21. Martin, S. F.; Dwyer, M. P.; Hartmann, B.; Knight, K. S. Cyclopropane-Derived Peptidomimetics. Design, Synthesis, and Evaluation of Novel Enkephalin Analogues. J. Org. Chem. 2000, 65, 1305-1318.
22. Martin, S. F.; Spaller, M. R.; Liras, S.; Hartmann, B. Enantio- and Diastereoselectivity in the Intramolecular Cyclopropanation of Secondary Allylic Diazoacetates. J. Am. Chem. Soc. 1994, 116, 4493-4494.
23. Stradley, S. J.; Rizo, J.; Gierasch, L. M. Conformation of a Heptapeptide Substrate Bound to Protein Farnesyltransferase. Biochemistry 1993, 32, 12586-12590.
24. Strickland, C. L.; Windsor, W. T.; Syto, R.; Wang, L.; Bond, R.; Wu, Z.; Schwartz, J.; Le, H. V.; Beese, L. S.; Weber, P. C. Crystal Structure of Farnesyl Protein Transferase Complexed with a CaaX Peptide and Farnesyl Diphosphate Analogue. Biochemistry 1998, 37, 16601-16611.
25. Hillier, M. C.; Davidson, J. P.; Martin, S. F. Cyclopropane-Derived Peptidomimetics. Design, Synthesis, and Evaluation of Novel Ras Farnesyltransferase Inhibitors. J. Org. Chem. 2001, 66, 1657-1671.
26. Martin, S. F.; Hom, R. K. Stereoselective Elaboration of Side Chain Residues in Cyclopropane-Containing Dipeptide Isosteres. Tetrahedron Lett. 1999, 40, 2887-2890.
27. Martin, S. F.; Hillier, M. C. Diastereodifferentiation in Intramolecular Cyclopropanations of Chiral Secondary Allylic Diazoacetates. Tetrahedron Lett. 1998, 39, 2929-2932.
28. Kempf, D. J.; Codacovi, L.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N. E.; Saldivar, A.; Vasavanonda, S.; Marsh, K. C.; Bryant, P.; Sham, H. L.; Green, B. E.; Betebenner, D. A.; Erickson, J.; Norbeck, D. W. Symmetry-Based Inhibitors of HIV Protease. Structure-Activity Studies of Acylated 2,4-Diamino-1,5-diphenyl-3-hydroxypentane and 2,5-Diamino-1,6-diphenylhexane-3, 4-diol. J. Med. Chem. 1993, 36, 320-330.
29. Martin, S. F.; Dorsey, G. O.; Gane, T.; Hillier, M. C.; Kessler, H.; Baur, M.; Mathae, B.; Erickson, J. W.; Bhat, T. N.; Munshi, S.; Gulnik, S. V.; Topol, I. A. Cyclopropane-Derived Peptidomimetics. Design, Synthesis, Evaluation, and Structure of Novel HIV-1 Protease Inhibitors. J. Med. Chem. 1998, 41, 1581-1597.
30. Waksman, G.; Shoelson, S. E.; Pant, N.; Cowburn, D.; Kuriyan, J. Binding of a High Affinity Phosphotyrosyl Peptide to the Src SH2 Domain: Crystal Structures of the Complexed and Peptide-Free Forms. Cell 1993, 72, 779-790.
31. Davidson, J. P.; Martin, S. F. Use of 1,2,3-Trisubstituted Cyclopropanes as Conformationally Constrained Peptide Mimics in SH2 Antagonists. Tetrahedron Lett. 2000, 41, 9459-9464.
32. Davidson, J. P.; Lubman, O.; Rose, T.; Waksman, G.; Martin, S. F. Calorimetric and Structural Studies of 1,2,3-Trisubstituted Cyclopropanes as Conformationally Constrained Peptide Inhibitors of Src SH2 Domain Binding. J. Am. Chem. Soc. 2002, 124, 205-215.
33. Liu, L.; Guo, Q.-X. Isokinetic Relationship, Isoequilibrium Relationship, and Enthalpy-Entropy Compensation. Chem. Rev. 2001, 101, 673-695.
34. Plake, H. R.; Sundberg, T. B.; Woodward, A. R.; Martin, S. F. Design and Synthesis of Conformationally Constrained, Extended and Reverse Turn Pseudopeptides as Grb2-SH2 Domain Antagonists. Tetrahedron Lett. 2003, 44, 1571-1574.
35. Rahuel, J.; Gay, B.; Erdmann, D.; Strauss, A.; Garcia, E.; Furet, P.; Caravatti, G.; Fretz, H.; Schoepfer, J.; Gruetter, M. G. Structural Basis for Specificity of Grb2-SH2 Revealed by a Novel Ligand Binding Mode. Nat. Struct. Biol. 1996, 3, 586-589.
36. Benfield, A. P.; Plake, H. R.; Millspaugh, L. E.; Teresk, M. G.; Martin, S. F. Ligand Preoganization May be Accompanied by Entropic Penalties in Protein-Ligand Interactions. Angew. Chem., Int. Ed., submitted for publication, 2006.